Search results Search results Search results

Search results

Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors

Press release

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy

Press release

Gimv sells majority stake in ALT Technologies to CCL Industries

Press release

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments

Press release

Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months

Press release

Announcement of share buyback in the context of a share purchase plan

Press release

Patricia Heymans

Team member

Cegeka Appoints Koen Deryckere as New Chief Executive Officer

Press release

Augustin Peyronne

Team member

Share buyback – update

Press release